Effect of Air Splints on Sensoriomotor Disturbances of the Affected Upper Extremity and Trunk Control in the Adult Post-stroke Patient
1 other identifier
interventional
20
1 country
1
Brief Summary
Objective: Sensory impairment in the affected upper limb occurs in approximately 50% of post-stroke patients and negatively impacts functional capacity and quality of life. This pilot study aims to evaluate whether the standardized use of pneumatic (air) splints, as part of a neurodevelopmental treatment approach, will have a positive effect on sensorimotor deficits in the hemiplegic upper limb of post-stroke patients. Design: Pilot randomized, single-blind clinical trial. Setting: Brain injury rehabilitation facility. Participants: Twenty adults in the subacute phase after stroke will be randomized into two groups. The experimental group (n = 10) will receive air splint therapy combined with physiotherapy (45 minutes per session, twice per week for 4 weeks). The control group (n = 10) will receive only physiotherapy with the same duration and frequency. Sensorimotor outcomes will be assessed using the Fugl-Meyer Assessment for the Upper Extremity (FMA-UE), and finger flexor/extensor strength will be measured using the Amadeo robotic system. Assessments will be conducted before and after the intervention. Conclusions: The addition of air splints to physiotherapy may enhance exteroceptive and proprioceptive sensitivity in adults recovering from stroke during the subacute phase.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 12, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2023
CompletedFirst Submitted
Initial submission to the registry
June 11, 2025
CompletedFirst Posted
Study publicly available on registry
June 19, 2025
CompletedJune 19, 2025
January 1, 2024
2 years
June 11, 2025
June 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in upper limb sensorimotor function measured by the Fugl-Meyer Assessment for the Upper Extremity (FMA-UE)
Change in upper limb sensorimotor function measured by the Fugl-Meyer Assessment for the Upper Extremity (FMA-UE), a validated stroke-specific scale. The FMA-UE ranges from 0 to 66, where higher scores indicate better motor and sensory function.
Baseline and post 4-week intervention
Secondary Outcomes (4)
Change in trunk function measured by the Trunk Control Test (TCT)
Baseline and after 4-week intervention
Change in balance performance measured by the Mini-Balance Evaluation Systems Test (Mini-BESTest)
Baseline and after 4-week intervention
Change in hand strength (flexion and extension) measured using the AMADEO robotic system.
Baseline and after 4-week intervention
Change in range of motion (ROM) of the shoulder and fingers measured using the AMADEO robotic system.
Baseline and after 4-week intervention
Study Arms (2)
Application of CPPS (Urias splints) + physiotherapy Intervention Type: Device
EXPERIMENTALPhysiotherapy alone following neurodevelopmental approach
NO INTERVENTIONInterventions
Application of CPPS (Urias splints) + physiotherapy
Eligibility Criteria
You may qualify if:
- Stroke at least 2 months earlier
- Mild/moderate hypertonia (Ashworth ≤3)
- Proprioceptive and exteroceptive deficits
- Trunk stability score between 8-23 (TCT)
You may not qualify if:
- Non-vascular etiology
- Clinical instability
- Skin lesions or deformities
- Botulinum toxin in last 3 months
- Cognitive/communication limitations
- Maximum TCT score (23) at baseline
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alfonso X El Sabio Universitylead
- Hospital Beata María Anacollaborator
Study Sites (1)
Alicia
Madrid, Madrid, 28007, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physiotherapist (PhD)
Study Record Dates
First Submitted
June 11, 2025
First Posted
June 19, 2025
Study Start
June 12, 2020
Primary Completion
June 12, 2022
Study Completion
March 10, 2023
Last Updated
June 19, 2025
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share